Holderness Investments Co’s Q3 vs Q4 2022 13F Holdings: Analysis of Trending Sectors and Company Changes
Ava Hoppe | 20 April, 2023
Holderness Investments Co Q3 2022 vs. Q4 2022 13F Holdings Comparison
Investors looking to invest in publicly traded companies often turn to funds to diversify their portfolio. One of these funds is Holderness Investments Co, which recently released its Q3 2022 vs Q4 2022 13F holdings comparison. This report shows the changes in the holdings of the fund, specifically comparing the shares and values of its holdings in Q3 2022 and Q4 2022.
The report covers a range of companies, including well-known names like Microsoft, Apple, and Amazon, as well as less recognized names such as Cirrus Logic and Truist Finl Corp. The report reveals a number of interesting trends in the way Holderness Investment Co has shifted its holdings over the past three months.
One of the most significant changes was in the holdings of Apple Inc, one of the world's largest technology companies. The report shows that the fund reduced its holdings in the company by 11.1 percent, going from 99816 to 94416 shares. Similarly, in Amazon, another tech giant, the holdings of the fund dropped by 26.9 percent, going from 98184 to 96590 shares.
However, in other companies, such as Applied Matls Inc and Pfizer Inc, the fund increased its holdings. For Applied Matls, the fund's holdings increased by 17.2 percent, from 70580 to 69625 shares, while for Pfizer Inc, the holdings increased by 16.3 percent, going from 109314 to 108591 shares.
Other interesting observations can be made from the Holderness Investments Co Q3 2022 vs Q4 2022 13F holdings comparison. For example, Cisco Sys Inc was another company where the fund increased its holdings, specifically by 18.2 percent from 69624 to 69086 shares. Although this was a minor shift in comparison to other companies, it still shows that the fund has an interest in this technology company.
Another notable trend was the sharp increase in the holdings of Caterpillar Inc, which rose by 47.1 percent from 9720 to 9793 shares. This was a significant boost, and shows that the fund has great faith in the company's future.
The report also reveals that, in general, the fund is favoring investments in the pharmaceutical and technology sectors. For example, the fund's holdings in Merck & Co Inc increased by 27.1 percent, from 34999 to 34530 shares, demonstrating a strong interest in the pharmaceutical industry.
Similarly, the fund's holdings in Intel Corp decreased by 11.7 percent, going from 79177 to 68147 shares. This decrease could reflect a shift away from traditional technology companies in favor of other areas of the sector.
Overall, the Holderness Investments Co Q3 2022 vs Q4 2022 13F holdings comparison shows an interesting and varied approach to investing. The report reveals both decreases and increases in holdings across a range of sectors, reflecting the portfolio managers' confidence in companies' future prospects.
Investors looking to diversify their portfolio or gain insights into investing may find the report particularly useful. By studying the trends and changes in the fund's holdings, investors can learn from the way professionals analyze and shift their investments. For these reasons, the Holderness Investments Co Q3 2022 vs Q4 2022 13F holdings comparison is a valuable resource for anyone interested in the world of investing.
Other Posts
- A Closer Look at Hammer Asset Management's Q3-Q4 2020 Portfolio Shifts
- Analyzing Centaurus Financial, Inc.'s Q3 2022 vs. Q4 2022 13F Holdings: Changes in Top Stock Holdings
- Flagship Harbor Advisors, LLC Q1 2023 vs. Q2 2023: A Detailed Analysis of 13F Holdings
- Investment Update: Financial Partners Group, Inc Q3 2022 vs. Q4 2022
- Navigating Uncharted Waters: Donald Quintin Steers Lone Star into New Horizons
- Argus Investors' Counsel, Inc. Q1 2023 vs. Q2 2023 13F Holdings Comparison
- Anne Arundel Dermatology Names Vincent Bradley as Chief Executive Officer
- Meridian Wealth Management's Q3 vs Q4 2022 Portfolio Analysis: Insights for Investors
- Investment changes at Brown Brothers Harriman & Co: A Q3 vs. Q4 2022 comparison
- Winslow Asset Management's Q4 2022 vs. Q1 2023: Investments in Apple and Teradyne Increase, Charles Schwab Declines Dramatically